Nicholas N. Vahanian
2017
In 2017, Nicholas N. Vahanian earned a total compensation of $3M as President at NewLink Genetics, a 33% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $184,200 |
---|---|
Option Awards | $2,192,081 |
Salary | $552,212 |
Other | $53,546 |
Total | $2,982,039 |
Vahanian received $2.2M in option awards, accounting for 74% of the total pay in 2017.
Vahanian also received $184.2K in non-equity incentive plan, $552.2K in salary and $53.5K in other compensation.
Rankings
In 2017, Nicholas N. Vahanian's compensation ranked 3,660th out of 14,666 executives tracked by ExecPay. In other words, Vahanian earned more than 75.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,660 out of 14,666 | 75th |
Division Manufacturing | 1,262 out of 5,772 | 78th |
Major group Chemicals And Allied Products | 355 out of 2,075 | 83rd |
Industry group Drugs | 273 out of 1,731 | 84th |
Industry Pharmaceutical Preparations | 216 out of 1,333 | 84th |
Source: SEC filing on April 9, 2018.
Vahanian's colleagues
We found four more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2017.